AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
77 hedge funds and large institutions have $135M invested in AVEO Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.
1,171% more call options, than puts
Call options by funds: $3.7M | Put options by funds: $291K
350% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 6
38% more funds holding
Funds holding: 56 → 77 (+21)
33% more capital invested
Capital invested by funds: $101M → $135M (+$33.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.69M |
| 2 |
GC
Globeflex Capital
San Diego,
California
|
+$2.83M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.63M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.49M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$5.09M |
| 2 |
Millennium Management
New York
|
-$3.78M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.6M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.54M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$241K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WFA
76
West Financial Advisors
Des Moines,
Iowa
| $1K | +$768 | +100 | New |
|
|
MOS
77
MGO One Seven
Beachwood,
Ohio
| $329 | – | – | – |
|
78
Group One Trading
Chicago,
Illinois
| – | -$59.2K | -7,706 | Closed |
|
|
SFG
79
Steward Financial Group
Colleyville,
Texas
| – | -$13K | -2,000 | Closed |
|
|
LFG
80
Larson Financial Group
St Louis,
Missouri
| – | -$4K | -566 | Closed |
|
81
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$1K | -100 | Closed |
|
AVEO Hedge Fund Activity: Q3 2022 in Review
77 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q3 2022, worth a combined $135M — up 33% from $101M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new AVEO positions and 6 closed out — a net gain of 21 holders — while 17 added to existing stakes and 17 trimmed.
The largest buyer was Rubric Capital Management (New York), adding an estimated $5.69M. The largest seller was J. Goldman & Co, cutting an estimated $5.09M.
- 77 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q3 2022, up from 56 in Q2 2022.
- Funds reported $135M of AVEO Pharmaceuticals, Inc. stock for Q3 2022, up 33% quarter-over-quarter.
- 27 funds opened new AVEO Pharmaceuticals, Inc. positions in Q3 2022 and 6 closed out, a net change of +21 holders.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q3 2022 was Rubric Capital Management (New York), an estimated $5.69M added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q3 2022 was J. Goldman & Co, an estimated $5.09M sold.
Based on aggregated 13F filings for Q3 2022.